The butyrate-m6A-BDNF axis: a hypothesis of gut-brain signal transduction in PSD
Abstract
A reduction in brain-derived neurotrophic factor (BDNF) protein levels has been reported in post-stroke depression (PSD). However, whether transcript abundance and translation efficiency change in parallel or become uncoupled in PSD remains to be determined. In addition to classical transcriptional regulation by histone deacetylase (HDAC) inhibitors, pathological processes may affect BDNF translation independently of transcription, but the relevant epitranscriptomic pathways remain unresolved. Drawing on reports that butyrate can influence m6A-related processes in peripheral tissues and that YTHDF1-dependent translation operates in adult hippocampus and cellular systems, this article proposes the “butyrate–m6A–BDNF” axis as a testable hypothesis. The hypothesis predicts that post-stroke changes in butyrate availability could alter central m6A regulation and thereby affect translation of a biologically motivated candidate transcript such as BDNF. The framework separates established mechanisms, cross-model evidence, and predictions that require direct measurement. The validation plan includes future exposure-resolved, genetic, and cell-type-specific studies; no validation experiments are presented here.
Related
- The influence of surface functionalization and signal transduction on electrochemical aptamer-based sensors
- Charge-screening dominates signal transduction in electrochemical nucleic acid sensors for aminoglycosides
- Butyrate Regulates the Blood–Brain Barrier Transport and Intraendothelial Accumulation of Alzheimer’s Disease Amyloid-Beta Peptides
- Co-evolution of RcsD and RcsF shapes signal transduction in the enterobacteriaceae Rcs system
- Mitochondrial subpopulations promote cellular responses to changes in metabolic demand and signal transduction
BibTeX
@article{wang2026butyratem6abdnf,
title = {{The butyrate-m6A-BDNF axis: a hypothesis of gut-brain signal transduction in PSD}},
author = {Shitao Wang and Shicong Zhao and Shuai Chen and Xiaoyu Wei and Hao Wang and Dajun Gu},
journal = {Frontiers in Neuroscience},
year = {2026},
month = nov,
doi = {10.3389/fnins.2026.1869522},
url = {https://www.frontiersin.org/articles/10.3389/fnins.2026.1869522},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The butyrate-m6A-BDNF axis: a hypothesis of gut-brain signal transduction in PSD
AU - Shitao Wang
AU - Shicong Zhao
AU - Shuai Chen
AU - Xiaoyu Wei
AU - Hao Wang
AU - Dajun Gu
PY - 2026
DA - 2026/11/04
JO - Frontiers in Neuroscience
DO - 10.3389/fnins.2026.1869522
UR - https://www.frontiersin.org/articles/10.3389/fnins.2026.1869522
AB - A reduction in brain-derived neurotrophic factor (BDNF) protein levels has been reported in post-stroke depression (PSD). However, whether transcript abundance and translation efficiency change in parallel or become uncoupled in PSD remains to be determined. In addition to classical transcriptional regulation by histone deacetylase (HDAC) inhibitors, pathological processes may affect BDNF translation independently of transcription, but the relevant epitranscriptomic pathways remain unresolved. Drawing on reports that butyrate can influence m6A-related processes in peripheral tissues and that YTHDF1-dependent translation operates in adult hippocampus and cellular systems, this article proposes the “butyrate–m6A–BDNF” axis as a testable hypothesis. The hypothesis predicts that post-stroke changes in butyrate availability could alter central m6A regulation and thereby affect translation of a biologically motivated candidate transcript such as BDNF. The framework separates established mechanisms, cross-model evidence, and predictions that require direct measurement. The validation plan includes future exposure-resolved, genetic, and cell-type-specific studies; no validation experiments are presented here.
SN - 1662-453X
ER -